导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -12.37% | 864/1050 |
| 近一周 | -2.91% | 780/1104 |
| 近一月 | -1.19% | 161/1102 |
| 近一季 | 3.03% | 157/1092 |
| 近半年 | -9.48% | 745/1070 |
| 近一年 | -18.37% | 876/1018 |
| 近两年 | 6.99% | 854/926 |
| 近三年 | -4.10% | 708/834 |
| 成立以来 | 78.53% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.99% 952/1070 |
-12.06% 960/1101 |
- - |
- - |
| 2025 | 2.73% 910/1065 |
1.59% 676/1014 |
0.97% 615/1038 |
3.46% 960/1050 |
-3.19% 613/1065 |
| 2024 | 6.48% 377/1011 |
1.47% 236/960 |
-8.22% 797/983 |
14.29% 273/991 |
0.04% 315/1011 |
| 2023 | -14.65% 508/952 |
1.64% 531/880 |
-12.56% 821/895 |
-5.72% 356/915 |
1.86% 69/952 |
| 2022 | -17.34% 232/867 |
-19.44% 487/773 |
14.89% 123/806 |
-14.75% 550/845 |
4.77% 216/867 |
| 2021 | -4.05% 405/740 |
-0.32% 163/580 |
9.25% 380/659 |
-16.10% 629/704 |
5.02% 223/740 |
| 2020 | 62.26% 181/554 |
-3.12% 238/419 |
22.68% 232/466 |
20.78% 52/517 |
13.04% 251/554 |
| 2019 | 41.05% 212/410 |
27.28% 528/1149 |
-4.16% 657/1231 |
7.22% 156/390 |
7.84% 244/410 |
| 2018 | -21.72% 100/349 |
- - |
- - |
- - |
-9.00% 209/1080 |
| 2017 | 45.09% 9/285 |
- - |
- - |
- - |
- - |
| 2016 | -6.33% 50/205 |
- - |
- - |
- - |
- - |
| 2015 | 17.17% 56/151 |
- - |
- - |
- - |
- - |
| 2014 | -5.54% 24/24 |
- - |
- - |
- - |
- - |
| 2013 | 8.58% 16/21 |
- - |
- - |
- - |
- - |
| 2012 | 3.96% 97/157 |
- - |
- - |
- - |
- - |
| 2011 | -17.64% 17/102 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 汇丰晋信消费红利股票 VS. 东吴新产业精选股票A(580008) |